Canton Hathaway’s Cantel Medical Corporation CMD Stock Holding History

Canton Hathaway’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,500	Closed	-$177K	–	206
2019 Q4	$177K	Sell	2,500 -1,500	-38%	-$109K	0.09%	85
2019 Q3	$299K	Hold	4,000	–	–	0.17%	68
2019 Q2	$323K	Hold	4,000	–	–	0.18%	55
2019 Q1	$267K	Buy	4,000 +500	+14%	+$37.9K	0.16%	62
2018 Q4	$261K	Buy	+3,500	New	+$289K	0.17%	51

Other funds holding CMD

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Diker Management New York $112M AUM 59.78% 1-Year Est. Return

Canton Hathaway's CMD Position: Q1 2020 in Review

Canton Hathaway sold out of Cantel Medical Corporation (CMD) in Q1 2020, closing a stake of 2,500 shares — an estimated $177K sold.

Canton Hathaway first reported a position in CMD in Q4 2018 and held it in 5 quarters. The position peaked at $323K in Q2 2019. 213 funds tracked by Wall St. Rank hold CMD as of Q1 2020.

Canton Hathaway reported no remaining Cantel Medical Corporation position as of Q1 2020 after selling out during the quarter.
Canton Hathaway sold 2,500 Cantel Medical Corporation shares in Q1 2020, an estimated $177K.
Canton Hathaway first reported a position in Cantel Medical Corporation in Q4 2018 and held it in 5 quarters.
Canton Hathaway's Cantel Medical Corporation position peaked at $323K in Q2 2019.
213 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2020.

Based on Canton Hathaway's 13F filing for Q1 2020, filed 6 May 2020.